医药废弃物管理市场、机会、成长动力、产业趋势分析与预测，2024-2032

2023 年全球药品废弃物管理市场价值为 47 亿美元，预计 2024 年至 2032 年复合年增长率为 7.6%。 ，并增加医疗保健支出。

由于人口老化、慢性病激增以及医学研究突破，药品需求不断增长，製药业蓬勃发展，正在推动市场成长。例如，联合国最近的一份报告预测，未来三十年，全球65岁以上人口将增加两倍，到2050年达到16亿，占全球人口的16%以上。这种人口结构的变化预计将产生大量的药品废弃物，这凸显出需要有效的废弃物管理系统来处理过期、未使用或受污染的药物。

医疗废弃物管理方面的持续创新、加强监管审查、向永续实践的转变以及对公共卫生和安全的加强关注正在推动该行业的成长。此外，随着全球对严格法规和合规标准的重视，製药公司和医疗保健提供者正在采用强有力的废弃物管理实务。监管机构强调安全处置製药废弃物，以减轻环境危害和公共卫生风险，从而增加对经过认证的废弃物管理服务和技术的需求。

医疗机构和製药公司越来越多地转向专业的第三方提供者来满足其废弃物管理需求。这种转变是由于废弃物法规的复杂性和处理危险物质所需的专业知识，刺激了废弃物管理服务业的成长。

整个製药废弃物管理产业根据废弃物类型、处理地点、废弃物产生者和地区进行细分。

2023年，包括一般药品废弃物、包装废弃物和其他无害材料在内的无害废弃物部分产生了最高收入，达36亿美元。这一增长是由非危险废物的增加带动的，包括需要妥善处置的未使用的、过期的和非处方药物。随着药物消耗的增加，对高效无害废弃物管理系统的需求也增加。无害废弃物处理方法的成本效益有助于医疗机构、药局和家庭采取适当的废弃物管理做法。

2023 年，异地处理领域以 59% 的主导份额引领市场。异地处理显着降低了医疗机构内部处理和加工製药废弃物的风险。透过将废弃物转移到专门的处理中心，组织可以降低污染、接触有害物质和潜在事故的风险。这些场外设施配备了必要的专业知识和基础设施，可安全地管理和处理不同类型的製药废弃物。他们经常利用先进的技术和设备，例如焚烧、化学处理和废物能源转化，这对较小的医疗机构来说可能不可行。他们处理大量废弃物并提供专业服务的能力进一步扩大了对场外处理的需求。

2023年，北美医药废弃物管理市场规模将达到17亿美元，预计2024年至2032年复合年增长率为7%。自动废弃物追踪、先进的焚烧方法和复杂的化学处理等创新正在提高製药废弃物管理的效率和安全性。这些技术的采用不仅可以促进市场成长，还可以确保更有效、更合规的解决方案。此外，企业社会责任（CSR）措施以及对永续实践的投资正在塑造区域市场前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 医疗保健支出和药物消费不断增加
    • 製药业的成长
    • 废弃物管理的技术进步
    • 关注医疗机构标准
  • 产业陷阱与挑战
    • 废弃物管理解决方案成本高昂
    • 废弃物分类面临的挑战
• 成长潜力分析
• 技术景观
• 监管环境
• 波特的分析
• PESTEL分析
• 处理药品废弃物的方法
• 价值链分析
• 差距分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按废弃物类型，2021 - 2032 年

• 主要趋势
• 危险废弃物
  • 传染性废弃物
  • 化学废弃物
  • 放射性废弃物
  • 其他危险废弃物
• 无害废弃物
  • 一般医药废弃物
  • 包装废弃物
  • 其他无害废弃物

第 6 章：市场估计与预测：按治疗地点分类，2021 - 2032 年

• 主要趋势
• 异地处理
• 现场治疗

第 7 章：市场估计与预测：按垃圾产生者分类，2021 - 2032 年

• 主要趋势
• 医院和诊所
• 製药和生物技术公司
• 药局
• 其他废弃物产生者

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Biomedical Waste Solutions
• BWS Incorporated
• Casella Waste Systems, Inc.
• Clean Harbors
• Cleanaway Waste Management Limited
• EcoMed Services
• Gamma Waste Services
• GRP and Associates, Inc.
• Hazardous Waste Experts
• MedPro Disposal
• REMONDIS SE and Co. KG
• Reworld Waste, LLC.
• Stericycle, Inc.
• VEOLIA ENVIRONNEMENT
• Waste Management, Inc.

The Global Pharmaceutical Waste Management Market was valued at USD 4.7 billion in 2023 and is projected to grow at a CAGR of 7.6% from 2024 to 2032. This growth is linked to advancements in waste treatment, heightened environmental concerns, more drug recalls and expired medications, and increasing healthcare expenditures.

Booming pharma sector, driven by rising demand for medications due to an aging population, a surge in chronic diseases, and breakthroughs in medical research, is pushing market growth. For example, a recent United Nations (UN) report forecasts that the global population aged 65 and over will triple in the next three decades, reaching 1.6 billion by 2050, which will constitute over 16% of the global populace. This demographic shift is expected to generate larger volumes of pharmaceutical waste, underscoring the need for efficient waste management systems to handle expired, unused, or contaminated drugs.

Continuous innovations in medical waste management, heightened regulatory scrutiny, a shift towards sustainable practices, and an intensified focus on public health and safety are driving the industry's growth. Additionally, with a global emphasis on stringent regulations and compliance standards, pharmaceutical companies and healthcare providers are adopting robust waste management practices. Regulatory bodies emphasize the safe disposal of pharmaceutical waste to mitigate environmental harm and public health risks, increasing demand for certified waste management services and technologies.

Healthcare facilities and pharmaceutical companies are increasingly turning to specialized third-party providers for their waste management needs. This shift is due to the intricate nature of waste regulations and the expertise required in handling hazardous materials, spurring growth in the waste management service industry.

The overall pharmaceutical waste management industry is segmented based on waste type, treatment site, waste generator, and region.

In 2023, the non-hazardous waste segment, encompassing general pharmaceutical waste, packaging waste, and other non-hazardous materials, generated the highest revenue of USD 3.6 billion. The growth is led by an uptick in non-hazardous waste, including unused, expired, and over-the-counter medications necessitating proper disposal. As medication consumption rises, so does the demand for efficient non-hazardous waste management systems. The cost-effectiveness of non-hazardous waste disposal methods facilitates proper waste management practices across healthcare facilities, pharmacies, and households.

In 2023, the offsite treatment segment led the market with a commanding share of 59%. Offsite treatment significantly reduces the risks tied to handling and processing pharmaceutical waste within healthcare settings. By transferring waste to specialized treatment centers, organizations can mitigate risks of contamination, exposure to hazardous substances, and potential accidents. These offsite facilities, equipped with the necessary expertise and infrastructure, can safely manage and treat diverse pharmaceutical waste types. They often utilize advanced technologies and equipment, such as incineration, chemical treatment, and waste-to-energy conversion, which may be unfeasible for smaller healthcare facilities. Their capability to process large waste volumes and offer specialized services further amplifies the demand for offsite treatment.

In 2023, North America pharmaceutical waste management market accounted for a substantial USD 1.7 billion and is projected to grow at a CAGR of 7% from 2024 to 2032. The region is leading the charge in adopting cutting-edge waste management technologies. Innovations like automated waste tracking, advanced incineration methods, and sophisticated chemical treatments are bolstering the efficiency and safety of pharmaceutical waste management. The adoption of these technologies not only enhances market growth but also ensures more effective and compliant solutions. Additionally, the Corporate Social Responsibility (CSR) initiatives, along with investments in sustainable practices is shaping the regional market outlook.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising healthcare expenditures and drug consumption
    • 3.2.1.2 Growth in the pharmaceutical industry
    • 3.2.1.3 Technological advancements in waste management
    • 3.2.1.4 Focus on healthcare facility standards
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of waste management solutions
    • 3.2.2.2 Challenges in waste segregation
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Methods of treating pharmaceutical waste
• 3.9 Value chain analysis
• 3.10 Gap analysis
• 3.11 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Waste Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hazardous waste
  • 5.2.1 Infectious waste
  • 5.2.2 Chemical waste
  • 5.2.3 Radioactive waste
  • 5.2.4 Other hazardous wastes
• 5.3 Non-hazardous waste
  • 5.3.1 General pharmaceutical waste
  • 5.3.2 Packaging waste
  • 5.3.3 Other non-hazardous wastes

Chapter 6 Market Estimates and Forecast, By Treatment Site, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Offsite treatment
• 6.3 Onsite treatment

Chapter 7 Market Estimates and Forecast, By Waste Generator, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceuticals and biotech companies
• 7.4 Pharmacies
• 7.5 Other waste generators

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Biomedical Waste Solutions
• 9.2 BWS Incorporated
• 9.3 Casella Waste Systems, Inc.
• 9.4 Clean Harbors
• 9.5 Cleanaway Waste Management Limited
• 9.6 EcoMed Services
• 9.7 Gamma Waste Services
• 9.8 GRP and Associates, Inc.
• 9.9 Hazardous Waste Experts
• 9.10 MedPro Disposal
• 9.11 REMONDIS SE and Co. KG
• 9.12 Reworld Waste, LLC.
• 9.13 Stericycle, Inc.
• 9.14 VEOLIA ENVIRONNEMENT
• 9.15 Waste Management, Inc.